Abstract
Among U.S. women, breast cancer is the most commonly diagnosed cancer (excluding skin cancers) and the second leading cause of cancer death, following lung cancer. In 2012, an estimated 226,870 new cases of invasive breast cancer and 39,510 breast cancer deaths are expected to occur among U.S. women. Breast cancer rates vary largely by race/ethnicity and socioeconomic status (SES), and geographic region. Death rates are higher in African American women than in whites, despite their lower incidence rates. Historically, breast cancer was recognized as a disease of western countries. However, over the past 20 years, breast cancer incidence and mortality rates have been increasing rapidly in economically less developed regions. According to 2008 GLOBOCAN estimates, half of the new worldwide breast cancer cases (1.38 million) and 60 % of the breast cancer deaths (458,000) occurred in developing countries. This chapter reviews breast cancer incidence and mortality patterns among women in the U.S. and worldwide, and the possible explanations for these patterns.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1):10–29
Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 19(8):1893–1907
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R et al (2008) Cancer survival in five continents: a worldwide population-based study. Lancet Oncol 9(8):730–756
Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598
NAACCR (2011) Surveillance, epidemiology and end results (SEER) program database (2011) CiNA Analytic File, 1995–2008, for expanded races, custom file with county, ACS facts and figures projection project, North American association of central cancer registries.www.seer.cancer.gov. Assessed 2011
National Cancer Institute (2012) SEER Surveillance, epidemiology, and end results registries. http://seer.cancer.gov/registries/index.html. Assessed 19 April 2012
National Program of Cancer Registries (2012) Centers for disease control and prevention. http://www.cdc.gov/cancer/npcr/about.htm. Assessed 6 April 2012
SEER (2011) Surveillance, epidemiology, and end results (SEER) program database www.seer.cancer.gov National cancer institute, DCCPS, surveillance research program, surveillance systems branch. Assessed April 2011
German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL et al (2011) The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35(2):126–131
GLOBOCAN 2008 v1.2 (2010) Cancer incidence and mortality worldwide: IARC CancerBase No. 10. International agency for research on cancer. http://globocan.iarc.fr.Assessed 20, April 2012
Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8):603–612
Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al (2011) SEER cancer statistics review, 1975–2008. National Cancer Institute Bethesda, Maryland
Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53(6):342–355
Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D et al (2005) Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448
Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56
Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR et al (2003) Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 95(20):1545–1548
Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: A review. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 17(11):2913–2923
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295(21):2492–2502
DeSantis C, Jemal A, Ward E (2010) Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control 21(9):1445–1450
Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control 20(4):417–435
Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI cancer surveillance monograph series, number 4. Bethesda, Maryland
Klassen AC, Smith KC (2011) The enduring and evolving relationship between social class and breast cancer burden: a review of the literature. Cancer Epidemiol 35(3):217–234
Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):409–418
Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236
Polednak AP (2005) Explaining geographic variation in breast and cervical cancer incidence rates in US Hispanic women. Ethn Dis 15(4):727–732
Laden F, Spiegelman D, Neas LM, Colditz GA, Hankinson SE, Manson JE et al (1997) Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 89(18):1373–1378
Canto MT, Anderson WF, Brawley O (2001) Geographic variation in breast cancer mortality for white and black women: 1986–1995. CA Cancer J Clin 51(6):367–370
Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN (1995) Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 87(24):1846–1853
Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. Ann of int med 156(7):491–499
Wun LM, Feuer EJ, Miller BA (1995) Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 6(2):135–144
Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99(15):1152–1161
Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s health Initiative randomized controlled trial. JAMA 288(3):321–333
Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9(3):R28
DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in U.S. women are no longer declining. Cancer epidemiology, biomarkers and prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology 20(5):733–739
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792
Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324–3330
CANCERMondial (2012) International agency for cancer research. http://www-dep.iarc.fr. Assessed 20, April 2012
Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22):1819–1827
Tominaga S (1985) Cancer incidence in Japanese in Japan, Hawaii, and western United States. Natl Cancer Inst Monogr 69:83–92
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol 8. Lyon, France
Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2):185–187
Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer 126(5):1187–1195
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34(2):405–412
Parkin DM (2009) Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 45(9):1649–1653
Seradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96(4):E1–E6
Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(11):641–644
Peto R, Boreham J, Clarke M, Davies C, Beral V (2000) UK and USA breast cancer deaths down 25 % in year 2000 at ages 20–69 years. Lancet 355(9217):1822
Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A et al (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit. Cancer 113(8):2221–22243
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ma, J., Jemal, A. (2013). Breast Cancer Statistics. In: Ahmad, A. (eds) Breast Cancer Metastasis and Drug Resistance. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5647-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5647-6_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5646-9
Online ISBN: 978-1-4614-5647-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)